Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase II Trial of Disulfiram With Copper in Metastatic Breast Cancer (DISC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03323346
Recruitment Status : Recruiting
First Posted : October 27, 2017
Last Update Posted : May 14, 2021
Sponsor:
Collaborator:
University Hospital Olomouc
Information provided by (Responsible Party):
The Institute of Molecular and Translational Medicine, Czech Republic

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 31, 2022
Estimated Study Completion Date : December 31, 2022
Publications: